台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    60.8
  • 漲跌
    ▼1.3
  • 漲幅
    -2.09%
  • 成交量
    33
  • 產業
    上櫃 文化創意指數
  • 105人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
智基 (6294)籌碼相關-元大-淡水 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-淡水 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/12/1300.00163.1063.10-189-1.12%
2024/11/20064.90166.1064.40-191-1.09%
2024/11/1900.001068.6269.30-1088-11.24%
2024/11/1800.00170.7070.70-190-1.10%
2024/11/14069.7000.0069.7001020.00%
2024/11/13177.4000.0077.401971.02%
2024/10/0900.00498.0097.40-4138-2.89%
2024/09/25197.10497.4097.70-3138-2.16%
2024/09/1300.00396.9396.80-3140-2.14%
2024/09/0600.000100.0099.5001370.00%
2024/08/2100.0015103.00102.00-15135-11.03%
2024/08/2000.009105.00104.50-9133-6.73%
2024/08/193107.1765106.42106.00-62130-47.62%
2024/08/1500.0029103.34102.50-29114-25.29%
2024/08/1416104.2200.00104.501611214.19%
2024/08/1300.0026104.52101.50-26109-23.81%
2024/08/1225102.8000.00102.50259925.17%
2024/08/0921100.54199.00100.50209321.44%
2024/08/082104.5000.00105.002952.09%
2024/08/0725108.001104.00108.00249724.53%
2024/08/06198.8000.00100.001901.11%
2024/08/05198.30099.5098.801891.10%
2024/07/315100.0000.00100.005895.62%
2024/07/2900.002100.50100.50-289-2.23%
2024/07/265100.5000.00101.005895.56%
2024/07/2300.003101.00101.50-390-3.33%
2024/07/221100.5000.00101.001901.10%
2024/07/194101.500101.50101.504894.44%
2024/07/041100.5000.00102.5011280.78%
2024/07/023101.5000.00101.0031342.24%
2024/06/2700.001100.50100.50-1136-0.73%
2024/06/261101.001100.00100.5001370.00%
2024/06/245100.5000.00100.5051393.59%
2024/06/2000.001101.00101.00-1142-0.70%
2024/06/190.1101.0000.00101.000.11430.03%
2024/06/180.1101.0000.00101.000.11450.03%
2024/06/122100.2500.00101.0021551.29%
2024/06/111102.0000.00101.5011560.64%
2024/06/058103.3100.00102.5081585.04%
2024/06/044102.5000.00103.0041582.52%
2024/05/272102.5000.00102.5021581.26%
2024/05/2200.000104.00103.000157-0.01%
2024/05/174106.0000.00105.5041522.63%
2024/05/1600.005106.00107.00-5150-3.33%
2024/05/1500.000105.50104.000148-0.01%
2024/05/1410.1100.9100.00102.0010.11446.95%
2024/05/130.1107.0000.00107.000.11270.08%
2024/05/070.1119.5000.00119.500.11190.04%
2024/04/2400.007117.50118.00-7115-6.05%
2024/04/1700.000116.00117.000111-0.01%
2024/04/120.1118.0000.00118.000.11040.05%
2024/04/112119.0000.00119.5021011.96%
2024/04/102126.250.5127.50127.001.5951.57%
2024/04/090124.5000.00124.000770.00%
2024/04/083.1123.5000.00123.503.1734.15%
2024/04/0300.002123.50123.50-271-2.80%
2024/04/012122.5000.00123.002692.87%
2024/03/293121.5000.00122.003684.40%
2024/03/200.1122.5000.00121.500.1560.09%
2024/03/190123.0000.00123.000550.02%
2024/03/1800.0024123.06124.00-2451-46.88%
2024/03/150122.0000.00121.500470.01%
2024/03/1300.0010117.00116.50-1039-25.47%
2024/03/120.5117.5000.00117.000.5381.29%
2024/01/290.1110.0000.00110.000.1300.16%
2024/01/220.1111.5000.00111.500.1290.17%
2024/01/190.9111.5000.00112.000.9293.14%
2024/01/090.1112.0000.00112.500.1270.18%
2024/01/030.1115.0000.00114.000.1250.19%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音